TL;DR
In vitro and in vivo studies demonstrate that ZnOov@DS-DOX effectively modulates tumor metabolic pathways, mitigates drug resistance, and enhances treatment outcomes, representing a significant advancement in nanomedicine and cancer therapy.
AI-generated by Semantic Scholar
Authors
Dong Kejun, Hu Hao, Cheng Shuangshuang, Mu Yaoqin, Zhang Wei, Zhou Ting, Zhang Jiarui, Shu Wan, Shen Xiaoyu, Wang Hongbo, Xiao Xianjin